These success, along with a previous report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 help the concept of targeting ACKR3 as a unique strategy to modulate the opioid technique, which could open new therapeutic avenues for opioid-similar Ailments. A investigate review published in Anesthesiology https://seymourq728kar3.blogoscience.com/profile